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Understanding the role played by autonomic tone changes in the initiation of paroxysmal
atrial ﬁbrillation (PAF) may be helpful in preventing the occurrence of the arrhythmia. The
purpose of this review article is to discuss the relationship between sympathovagal imbalance
and the initiation of PAF from past literature and our data regarding circadian distribution and
heart rate variability (HRV) analysis in PAF. PAF in non-structural heart disease (NHD)
frequently occurs during evening and night hours with a longer duration of each episode, and
its initiation is directly associated with an increase in vagal tone. According to our data of
HRV analysis in NHD, HF power (indicator of vagal tone) showed a reduction 15 to 30
minutes before PAF, followed by a sharp increase immediately before the onset, suggesting
a primary increase in sympathetic tone followed by a marked changes toward vagal
predominance. Very few studies have been reported on PAF onset or the modulation of
autonomic tone in structural heart disease (SHD). Some studies showed no signiﬁcant
diﬀerences in the circadian variation of the onset between NHD and SHD. However, we
demonstrated a triphasic circadian pattern with maximum peaks in early morning, late
afternoon, and night in SHD, suggesting an association with not only a vagally induced origin
but also a sympathecally induced or stress triggered origin in PAF onset in SHD. The
occurrence of PAF greatly depends on modulation of autonomic tone and is extremely
complicated. Further studies are required to clarify the relationship between the occurrence of
PAF and autonomic modulation.
(J Arrhythmia 2008; 24: 122–132)
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Introduction
Circadian distribution has been reported in some
cardiovascular disorders such as acute myocardial
infarction,1–3) sudden cardiac death,4,5) transient
myocardial ischemia6,7) and stroke,8) with a predom-
inance of incidents occurring in the early morning.
One reason for this is considered to be related to an
abrupt change from a predominantly vagal tone to
a dependent sympathetic tone in the early morning.
Ventricular premature contractions and supraven-
tricular premature contractions have been known to
demonstrate circadian ﬂuctuation patterns with high
reproducibility in each patient; daytime, nighttime
and both day- and nighttime onset, and irregular
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occurrence.9–11) There are also many reports regard-
ing the circadian distribution of the occurrence of
episodes of paroxysmal supraventricular tachycardia
(PSVT).12–19)
In recent years, heart rate variability (HRV)
analysis has enabled us to provide a quantitative
evaluation of sympathovagal interaction in patients
with cardiac disorders. Reduced vagal and aug-
mented sympathetic activities have been increas-
ingly linked to life-threatening ventricular arrhyth-
mias, sudden cardiac death, total mortality after
myocardial infarction, and congestive heart fail-
ure.20–23) Alterations in sympathovagal balance with
reduced vagal and increased sympathetic outﬂow
to the heart are also reported in patients with
advanced hypertrophic and dilated cardiomyop-
athy.24)
Atrial ﬁbrillation is a common arrhythmia with
or without structural heart disease.25) Especially,
initiation of paroxysmal atrial ﬁbrillation (PAF) in
patients with non-structural heart disease (NHD) is
reportedly associated with speciﬁc circadian distri-
bution13,15–18,26–30) and with changes of sympathetic
or vagal tone seen clinically31–33) or with HRV
analysis.28,34–38)
In this article we reviewed the circadian distribu-
tion of PAF and the eﬀect of autonomic tone
modiﬁcation on PAF initiation.
Holter monitoring and atrial ﬁbrillation
Holter monitoring is an indispensable tool for
detection, diagnosis, or management of arrhythmia.
In order to learn which clinical and basic uses of
Holter monitoring have been favored by cardiolo-
gists around the world, a search for ‘Holter monitor-
ing’ was done from literature included in PUBMED/
MEDLINE.39) The 10 most prevalent topics from a
search for ‘Holter monitoring’ for literature pub-
lished between January 2002 and March 2007 are
shown in Figure 1. The most frequently observed
subject was ‘heart rate variability (HRV),’ which
was found in 182 out of 1,885 articles followed
by ‘atrial ﬁbrillation’ in 99 articles. Thus, Holter
monitoring is frequently used to investigate HRV
and atrial ﬁbrillation.
Figure 2 shows the 10 most prevalent topics
obtained from a search for ‘Holter monitoring
and atrial ﬁbrillation’ between January 2000 and
March 2007 in articles included in PUBMED/
MEDLINE.39) Among them, the seventh most
prevalent topic was ‘autonomic nervous system’.
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Figure 1 Top 10 topics among 1885 articles from a PUB/MED search for ‘Holter monitoring’ between Jan 1, 2002
and March 31, 2007.
HRV: heart rate variability, CAD: coronary artery disease, MI: myocardial infarction
Tanabe T Circadian Distribution and Autonomic Tone Modulation in Paroxysmal Atrial Fibrillation
123
Circadian distribution of supraventricular
tachyarrhythmias
1. Paroxysmal supraventricular tachycardia
PSVT, PAF and atrial ﬂutter are well known
supraventricular tachyarrhythmias with episodes of
paroxysms. Table 1 shows review literature inves-
tigating circadian variation in the onset of supra-
ventricular tachyarrhythmias including PAF and
PSVT. Irwin et al.14) observed a peak incidence of
PSVT in the afternoon and evening with a maximum
at 4:00 pm. Regarding the PSVT, there is relatively
broad consensus that episodes occur mainly during
the afternoon.17,18) However, there are studies dem-
onstrating a double-peak with a peak occurring with
PSVT in the morning in addition to the afternoon
peak.16,19) Plasma concentration was higher during
the daytime (8:00 am to 6:00 pm) than at night in
patients with essential hypertension.40) The reason
for this high incidence of PSVT mainly in the
afternoon or early morning may be based on an
acceraration in electrophysiologic conduction of the
atrioventricular node induced by adrenergic preva-
lence.41) As a matter of fact, the abolition of the
morning peak induced by -blockers is consistent
with this hypothesis.16)
2. Paroxysmal atrial ﬁbrillation
There are many studies on circadian distribution
of the onset of PAF.15–18,26–30) Some of them have
demonstrated a double-peak occurrence of PAF with
morning and evening,16,29) whereas the otherers
showed peaks during midnight and in the morning,17)
or after lunch and at midnight.27) Also, there are
studies demonstrating a much higher occurrence
during the day than at night,26,28) triple peaks—noon
to 2:00 pm, 6:00 pm to 2:00 am and 4:00 am to
6:00 am,30) and no circadian distribution.18) The data
for PAF showing a peak incidence during the night
are completely diﬀerent from those for PSVT in
which episodes mainly occurred in the afternoon.
The mechanisms responsible for this diﬀerence are
not clear.
Experimentally, atrial ﬁbrillation can be initiated
by application of acetylcholine to the localized
region of the auricular surface.42) Clinically, in
patients with frequent PAF episodes, especially with
NHD, the onset of paroxysms is often associated
with an increase in vagal tone.31,32) Therefore, a
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Figure 2 The 10 most prevalent topics among 618 articles in PUB/MED search for ‘Holter monitoring and atrial
ﬁbrillation’ between Jun 1, 2000 and March 31, 2007.
AF: atrial ﬁbrillation.
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subset of PAF has the increase in vagal tone as a
partial mechanism since the above periods with a
peak incidence of PAF during the night may be
characterized by predominance of vagal tone.
However, most of the past studies vary greatly as to
the circadian distribution of the onset of PAF, as
described previously. Their weakness is that they do
not measure the true circadian variation of PAF
because they included only patients with symptomat-
ic episodes,16–18,29) those with unusual circumstances
such as emergency room16) or mobile coronary care
unit,17) those taking antiarrhythmic drugs including
-blockers,16,26,29) those with event ECG recorder or
transtelephonic transmission of ECG,18,29) and those
with both structural heart disease (SHD) and
NHD.16–18,28) Furthermore, some studies did not
describe whether the patients were on antiarrhythmic
drugs including -blockers,19,21,23,29) although this is
a very important aspect.
Nevertheless, only one paper, which was pub-
lished by Yamashita et al.,27) precisely described the
patient characteristics of NHD, absence of drug
therapy and inclusion of both symptomatic and
asymptomatic subjects. They analyzed the circadian
variation not only at the onset of PAF but also the
hourly total duration, maintenance and termination
Table 1 Literatures reviewed from investigation of the circadian distribution of proxysmal atrial ﬁbrillation atrial (PAF) and
paroxysmal supraventricular tachycardia (PSVT).
Author Publish(year)
Nos. of
patients
(men/women)
Mean
age
(y.o)
Arrhythmia
(Nos. of
episodes)
Underlying HD
(Nos. of
patients)
Drugs symptomatic (S) or
asymptomatic (A) Peak time of incidence
Irwin JM, et al. 1988 52 (?) 46:2 15:7 PSVT(52) presence non
S, telephone
contact or regular
clinic visits
PSVT: afternoon and evening,
with peak at 4 pm
Kupari M, et al. 1990 251 (170/81) 49 PSVT (69),PAF (152)
presence (127)
absence (82)
AAD,
-blocker
S, emergency
room
PAF: double-peaking with eve-
ning and morning.
PSVT: morning
Rawles JM, et al. 1990 72 (?) 72 (34-93) PAF(139)
not
described
AAD,
-blocker,
Digoxin
S & A,
Holter
monitoring
PAF: more often by day than
by night
Rostagno C, et al. 1993 1,118 (?) notdescribed
PSVT (348),
PAF (726)
presence,
absence
not
described
S, mobile
coronary
care unit
PAF: with a peak between
midnight and 2 am. With sec-
ondary peak in the morning (8
to 9 am).
PSVT: during the daytime
Clair WK, et al. 1993 150 (79/71) notdescribed
PSVT (92),
PAF (34)
presence,
absence
drug
free
S, event ECG
recorder and
telephone
transmission
PAF: no circadian distribution.
PSVT, with peak at approxi-
mately at 6 pm.
Yamashita T, et al. 1997 150 (120/30) 61:6 12:8 407 PAF(407) absence
drug
free
S & A,
Holter
monitoring
PAF: with a double peak after
lunch and at midnight
Huang JL, et al. 1988 57 (34/23) 66 22 PAF(121)
presence (27)
absence (30)
not
described
S & A,
Holter
monitoring
PAF: the most common onset
time between 4:00 am and
4:00 pm (40/63). No different
circadian distribution pattern
between vagal and sympathet-
ic type PAF.
Lee SH, et al. 1999 105 (?) notdescribed
PAF
(498)
not
described
drug
free
S & A,
Holter
monitoring
PSVT: with a peak during day-
time, especially with peaks at
8:00 am to 9:00 am, 12:00 pm
to 1:00 pm, and 5:00 to
6:00 pm.
Viskin S, et al. 1999 3,343(1,872/1,471) 74:3 12
PAF
(9,989)
presence,
absence
AAD
and
other
drugs
S, event
ECG recorder
and telephonic
transmission
PAF: with a double peak with
a signiﬁcant increase in the
morning and and a second rise
in evening
Vincenti A, et al. 2005 90 (58/32) 67.7 (34-93) PAF(233) presence (28)
not
described
S & A,
Holter
monitoring
PAF: triple peaks with noon to
2:00 pm, 6:00 pm to 2:00 am,
and 4:00 am to 6:00 am.
Tanabe T Circadian Distribution and Autonomic Tone Modulation in Paroxysmal Atrial Fibrillation
125
of the arrhythmia from 150 Holter recordings with a
total of 407 episodes of PAF in a drug-free state with
NHD. They demonstrated non-uniformity of hourly
total duration across the 24 hours, reﬂecting a non-
random occurrence of PAF throughout the day, with
an increase at night with a peak at about midnight
and a decrease in the morning with a nadir at about
11:00 am. The incidence of onset was also non-
uniformly distributed throughout the 24-hour period
because it showed a double peak with increases after
lunch and at midnight. However, the probability of
onset could not be ﬁtted to a single- or double-
harmonic curve, although the incidence had a weak
double-peaked diurnal rhythm (Figure 3A). In con-
trast, they observed signiﬁcant circadian variations
for both the maintenance period and termination of
PAF: a sharp decline in the morning to a nadir at
about 10:00 am and then a gradual increase after
lunch in the maintenance period and a double-curve
with peaks at 11:00 am to 12:00 pm and 10:00 pm
to 11:00 pm. The authors suggested that the main-
tenance and termination of PAF showed more
distinct circadian variations compared with the onset
(Figure 3B, C).
There are very few reports which compare the
circadian distribution of the onset of PAF between
SHD and NHD. Kupari et al.16) and Rostagno
et al.17) described that no signiﬁcant diﬀerences in
the circadian variation of the onset of PAF existed
between the 2 groups. However, they included
only patients with symptomatic episodes who were
admitted to hospital in unusual circumstances
such as emergency room or mobile coronary care
unit, and took antiarrhythmic drugs including -
blockers.
We conducted a study of the circadian distribution
of the hourly total duration, onset, maintenance and
termination of PAF using Holter monitoring method
in a drug-free state, which was similar to the protocol
of Yamashita et al.27) comparing SHD and NHD
patients. As a result, the circadian distribution at
onset of PAF throughout 24 hours showed a marked
diﬀerence between the 2 groups. The SHD group
showed a triphasic circadian pattern with maximum
peaks in the late afternoon, between late evening and
night, and in the early morning, whereas the NHD
group had a single harmonic peak between late
evening and midnight (Figure 4). The coeﬃcients of
the two groups were signiﬁcant (p < 0:05 in SHD
and p < 0:01 in NHD). The circadian distribution of
the probability of termination of PAF in SHD was
demonstrated with a peak around noon and with
a nadir at around midnight with a signiﬁcant diﬀer-
ence in the distribution (p < 0:05) (Figure 5). On the
other hand, in the distribution in the NHD group, a
weak double-peaks at around 6:00 am–11:00 am and
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0 2 4 6 8 10 12 14 16 18 20 22
1
0.8
0.6
0.4
0.2
0
C.  Probability of Termination
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0.5
0.4
0.3
0.2
0.1
0
Clock Time (hours)
A.  Probability of Onset
0.2
0.15
0.1
0.05
0
0 2 4 6 8 10 12 14 16 18 20 22
Figure 3 Hourly probability of paroxysmal atrial ﬁbrillation
episodes (A: onset, B: maintenance, C: termination) (from
Yamashita T et al: Circadian variation of paroxysmal atrial
ﬁbrillation. Circulation 1997; 96: 1537–41 Reference No. 27).
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8:00 pm–0:00 am were demonstrated although not
signiﬁcant (p ¼ 0:063). This observation in the NHD
group was similar to the outcome obtained by
Yamashita et al.27) with a double-curve with peaks
at 11:00 am to 12:00 pm and 10:00 pm to 11:00 pm.
Therefore, it may be an indication that spontaneous
cessation of PAF occurs in the morning until around
noon and in the late evening.
Dynamic changes in autonomic tone in the
onset and termination of PAF
In recent years, autonomic tone has been easily
and noninvasively measured by heart rate variability
(HRV) analysis. In particular, the measurement of
autonomic tone in humans plays a critical role
because reduced vagal and augmented sympathetic
activities are reported to be an independent predictor
of sudden cardiac death and total mortality in
patients with prior myocardial infarction43–45) and
chronic heart failure.46,47) On the other hand, HRV
analysis is also important for investigating altera-
tions of neural regulatory mechanisms in the genesis
of arrhythmias. As a matter of fact, changes in
autonomic tone before the onset of spontaneous
idiopathic ventricular tachycardia has been inves-
tigated and the relationship between autonomic
nerve activity and life-theatening ventricular ar-
rhythmias has been studied in patients with a variety
of underlying heart disorders.23)
Coumel31–33) is the ﬁrst to demonstrate PAF
related to vagotonic or sympathetic activity from
initiation and its relation to ﬂuctuation in autonomic
tone, but his classiﬁcation was done from clinical
observations without HRV analysis. Table 2 shows
authors, underlying heart disease, drugs administered
and outcome of HRV analysis in reviewed literature
of studies on HRV before the onset of PAF. Huang
et al.28) classiﬁed 3 subtypes according to the HRV
analysis before the onset of PAF: onset of PAF
accompanied with increased high-frequency compo-
nent (HF) and decreased low-frequency component
(LF)/HF ratio before the PAF onset designated
as the vagal type; decreased HF component and
increased LF/HF ratio designated as the sympathetic
type; and other episodes which did not belong to
vagal or sympathetic type designated as the non-
related type. As a result, vagal type was predominant
(41/63 episodes, 63.5%) in NHD PAF group
(idiopathic PAF) whereas sympathetic type was
predominant (39/58 episodes, 67.2%) in SHD PAF
group.
Other studies also demonstrated strong connection
between an increase in HF or increased vagal
hour of
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Number of PAF episodes
SHD  (131 episodes)
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Figure 4 Circadian distriburion of the onset of paroxysmal atrial ﬁbrillation–comparison between structural (SHD)
and non-structural (NHD) heart diseases.
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activity with nighttime initiation PAF, and that of an
increase in LF/HF and an decrease in HF or
increased sympathetic activity with daytime initia-
tion PAF in patients in a drug-free state with
structurally normal heart.34,38) Fioranelli et al.35)
investgated changes in sympatho-vagal balance only
within 5 minutes before the onset of PAF in patients
in a drug-free state without structural cardiac
diseases. They observed two types of abrupt changes
in sympatho-vagal balance even in the last 5 minutes
preceding an episode of PAF; Type A with an
increase of LF and LF/HF and a decrease of HF, and
Type B with a reduction of LF and LF/HF and an
increase of HF.
An increase in vagal tone reportedly shortens the
atrial refractory period, augmentation of heteroge-
neity of refractoriness and facilitate intraatrial
reentry.48) Strengthened sympathetic tone is likely
to induce automaticity and delayed afterdepolariza-
tion.49) Therefore, any changes in individual vagal or
sympathetic tone, or sympatho-vagal imbalance may
initiate PAF.
It is widely recognized that premature beat foci
located at or near the oriﬁce of the pulmonary veins
are often involved in the genesis of PAF.50–52)
Zimmemann and Kalusche36) analyzed dynamic
changes in autonomic tone preceding the onset of
PAF with proven pulmonary vein origin. They
concluded that episodes of focal PAF originat-
ing from pulmonary veins are mainly dependent
on variations of autonomic tone, with a signiﬁ-
cant shift toward vagal predominance before PAF
onset.
Bettoni and Zimmermann37) analyzed dynamic
change in autonomic tone preceding the onset of
PAF by measuring HRV in a total of 147 episodes of
the arrhythmia; the 24-hour period, one hour before
the PAF onset and the 20 minutes before PAF
divided into four 5-minute periods. Their observa-
tions were interesting with regards to suggesting
a primary increase in adrenergic tone followed by
a marked modulation toward vagal predominance
before the onset of PAF. The reason for this
interpretation was that the LF/HF ratio showed a
linear increase until 10 minutes before the arrhyth-
mia, followed by a sharp decrease immediately
before it. They also demonstrated a signiﬁcant
alteration in SDANN (standard deviation of RR
intervals) and SDNN (standard deviation of the
averages of RR intervals for 5 minute segments)
parameters of time domain analysis of HRV, and an
increase in atrial ectopy in the minute before the
PAF onset in more than 50% of patients. Increased
frequency of atrial premature beats before the onset
hour of
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Figure 5 Circadian distribution of the termination of atrial ﬁbrillation: comparison between structural (SHD) and
non-structural (NHD) heart diseases.
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of PAF may result in an enlarged standard deviation
of RR intervals and a subsequent incorrect interpre-
tation as an increase of vagal predominance. There-
fore, HRV should be evaluated without preceding
atrial premature beats before the onset of PAF. In
this regard, we studied PAF patients with NHD in
untreated state and having one or zero premature
beats every minute for 5 minutes before the onset of
the arrhythmia divided into 4 time periods: morning
(6:01 am to 12:00 pm), afternoon (12:01 pm to
6:00 pm), evening (6:01 pm to 0:00 am) and night
(0:01 am to 6:00 am). Figure 6 shows the changes in
HF and LF/HF in the evening onset PAF from just
before to 120 minutes before the onset of the
arrhythmia. Signiﬁcanly accelerated HF power and
reduced LF/HF ratio just before the PAF onset as
compared to 5 to 10 minutes before the onset are
observed. Interestingly, note that accelerated HF just
before the onset of PAF is preceded by a reduction
in HF and reduced LF/HF just before the onset of
arrhythmia is preceded by a increase in LF/HF ratio
as compared to those parameters 15 to 30 minutes
before the onset. These observations may be an
indication that the initiation of PAF needs a
reduction in vagal tone or an increase in sympathetic
tone, or both about 20 minutes before the onset, and
then a sharp increase in vagal tone just before the
onset, especially in evening onset PAF.
Tomita et al.38) evaluated HRV parameter changes
in a 10-minute segments at 60 minutes, 20 minutes,
and at time of onset, not only before the onset of
PAF but also after its termination in 23 patients with
NHD. They showed a signiﬁcant decrease in HF and
LF components after the termination of PAF in
group N (n ¼ 14), in which PAF began at night and
was preceded by a gradual increase in HF and LF.
This group, however, demonstrated no changes in
the LF/HF ratio both before and after the arrhyth-
mia. In contrast, group D (n ¼ 9), in which PAF
occurred during the daytime, showed a signiﬁcant
increase in the LF/HF ratio before PAF and a
decrease in LF and the LF/HF ratio after PAF,
Table 2 Literatures reviewed from investigation of heart rate variability before the oneset of paroxysmal atrial ﬁbrillation
(PAF).
Authors Publishyear
Nos. of
patients
(men/women)
Mean
age
y.o.
Underlying HD
(Nos. of patients) Drugs Outcome of HRV analysis
Huang JL, et al. 1998 57 (34/23) 66 22 presence (27)
absence (30) not described
A signiﬁcant increase in HF in majority of
idiopathic PAF (41/63 episodes) and a signiﬁ-
cant increase in LF/HF ratio (39/58 episodes) in
prganic heart disease PAF.
Herweg B et al. 1998 29 (18/11) 61 13
presence
(16 including
6 HT)
absence (13)
Digoxin,
-blockers,
Ca-blockers
Contrary to daytime PAF, an increase in vagal
activity preceded predomonantly nocturnal PAF,
mostly in younger patients with structurally
normal heart.
Fioranelli M et al. 1999 28 (20/8) 60 11 absence (28) drug-free
Abrupt HRV changes in the last 5 minutes
before the onset of PAF. One group revealed an
increase in LF and LF/HF, and a decrease in HF
suggesting an enhancement of sympathetic
drive. The other demonstrated a reduction of
LF and LF/HF, and an increase in HF consistent
with an enhancement of vagal drive.
Zimmermann M et al. 2001 13 (10/3) 53 5
absence and
pro
ven pulmonary
vein origin (13)
drug free
(11 pts, 85%)
Pulmonary vein origin AF are mainly dependent
on variations of autonomic tone, with a signiﬁ-
cant shift toward vagal predominance before AF
onset.
Bettoni M et al. 2002 77 (63/14) 58 12 absence
amiodarone (9 pts),
-blockers (18 pts),
digoxin (10 pts)
PAF onset greatly depends on variations of
autonomic tone, with a primary increase in
adrenergic tone followed by an abrupt shift
toward vagal predominance.
Tomita T et al. 2003 23 (12/11) 65 2 absence drug-free
PAF was preceded by a gradual increases in HF
and LF component without changes of LH/HF
ratio in the nighttime initiation PAF. Conversly,
daytime initiation PAF group demonstrated a
signiﬁcant increase in the LF/HF ratio before
PAF without changes in HF.
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but no changes in HF. Consequently they suggested
that the autonomic nervous system played an
important role in both the initiation and termination
of PAF.
By looking at the variety of studies mentioned
above, there is a consensus on the onset mechanism
of PAF regarding the ﬂuctuation of autonomic tone
in patients with NHD. It frequently initiates during
the night and is strongly associated with a sharp
increase in vagal tone just before the onset. Some
studies emphasize that such a sharp increase of vagal
tone is often preceded by a reduction of vagal tone or
an increase of sympathetic tone. Very few studies are
reported on the autonomic initiation mechanism of
PAF in patients with SHD. Some studies demon-
strate no change in circadian distribution of PAF
onset between NHD and SHD patients. In contrast,
our SHD patients showed a triphasic circadian
pattern with maximum peaks in the late afternoon,
between late evening and night, and in the early
morning. Therefore, the autonomic onset mecha-
nism in SHD seems very complicated compared
to that in NHD. Further study is needed regarding
this.
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